CPRIT awarded $1,173,420 to Navin Varadarajan, associate professor of chemical and biomolecular engineering, to improve the effectiveness of T-cell immunotherapy for cancer patients.
Varadarajan will use his grant to bring consistent results to cancer patients undergoing T-cell immunotherapy by manufacturing programmed T cells to meet, recognize and destroy tumors.
That’s what the immune systems’ T cells are for; by nature they fight invaders or infections.